Simultaneous Determination of Eight Antiepileptic Drugs and Two Metabolites in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry
Hengyi Yu,Xiuhua Ren,Lu Liu,Dong Xiang,Xiping Li,Juan Li,Dong Liu,Xuepeng Gong
DOI: https://doi.org/10.1556/1326.2022.01024
2023-04-26
Acta Chromatographica
Abstract:Epilepsy is one of the most prevalent neurological conditions and antiepileptic drugs are the mainstay of epilepsy treatment. High variation in pharmacokinetic profiles of several antiepileptic drugs highlights the importance of therapeutic drug monitoring to estimate pharmacokinetic properties and consequently individualize drug posology. In this work, a simple, rapid and robust liquid chromatography-tandem mass spectrometry method was developed for simultaneous quantification of carbamazepine and its metabolite carbamazepine-10,11-epoxide, gabapentin, levetiracetam, lamotrigine, oxcarbazepine and its metabolite mono-hydroxy-derivative metabolite, phenytoin, topiramate, and valproic acid in human plasma for therapeutic drug monitoring. d 6 -Levetiracetam, d 4 -gabapentin and d 6 -valproic acid were used as internal standards. After addition of internal standards along with two-step protein precipitation and dilution sample preparation, plasma samples were analyzed on a C 18 column using a gradient elution in 5 min without interference. The calibration curves were linear over a 100-fold concentration range, with correlation coefficients ( r 2 ) greater than 0.99 for all analytes. The limit of quantification was 0.5 μg/mL (0.1 μg/mL for oxcarbazepine, 2 μg/mL for levetiracetam, and 10 μg/mL for valproic acid) with precision and accuracy ranging from 2.84% to 9.02% and from 94.06% to 112.26%, respectively. Intra- and inter-day precision and accuracy values were within 15% at low, medium and high quality control levels. No significant matrix effect was observed in the normal, hemolyzed, lipemic, and hyperbilirubin blood samples. This method was successfully used in the identification and quantitation of antiepileptic drugs in patients undergoing mono- or polytherapy for epilepsy.
chemistry, analytical